Because they have over $100 mill of tangible equity let alone the 350 stores and a quality brand etc.
This impairment will hit short term profit but be good for cashflow longer term etc.
15c would bring the Market Cap to around $40mill
Yes, it is possible that it could touch that - but I would not be putting money on it that is for sure - it would be valuing the whole business like a spec stock (it already is)
(PS - same reason as with SRX, there was a quality business there and the market just bid it back up - the rationale for the comparison was only that it started at $15 after the news of the failed trials and didn't drop back)
- Forums
- ASX - By Stock
- DSH
- Fair Price
Fair Price, page-121
Featured News
Add DSH (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online